Table 8.
Mycotoxin, μg/kg | Phase | 1 | 2 | 3 | |||
---|---|---|---|---|---|---|---|
Diet 1 | LM | HM | LM | HM | LM | HM | |
Aflatoxin B1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 43.7 | |
Aflatoxin B2 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | |
Aflatoxin G1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
Aflatoxin G2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
Deoxynivalenol | 501 | 1534 | 524 | 1837 | 1050 | 3956 | |
3-acetyl-deoxynivalenol | 2.3 | 28.6 | 2.3 | 29.7 | 2.3 | 25.2 | |
15-acetyl-deoxynivalenol | 145 | 521 | 154 | 543 | 106 | 435 | |
Deoxynivalenol-3-glucoside | 11 | 11 | 11 | 11 | 152 | 220 | |
Nivalenol | 49.9 | 49.9 | 49.9 | 49.9 | 49.9 | 49.9 | |
Fusarenon-X | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 | |
Fumonisin B1 | 130 | 156 | 219 | 239 | 53 | 1,289 | |
Fumonisin B2 | 40.9 | 41.7 | 39.1 | 19.0 | 1.8 | 67.5 | |
Fumonisin B3 | 5.0 | 5.0 | 5.0 | 5.0 | 5.0 | 41.3 | |
Zearalenone | 3 | 3 | 128 | 242 | 3 | 43 |
Mycotoxin concentrations were measured at the Analytical Services Laboratory of Alltech Inc. Laboratory (37+™, Alltech Inc., Nicholasville, KY, USA). The detection limit was used for variables not detected. Levels of mycotoxins reported considered values above the limit of quantitation of each mycotoxin, the relative standard deviation (<20%), and the signal to noise ratio (>10). 1 Postbiotic yeast cell wall-based blend (PYCW) was added to LM and HM at 0.2% in all phases to create two other dietary treatments at each phase.